CERO THERAPEUTICS HOLDINGS, INC. - 8-K Filing

Cero Therapeutics agrees to sell subsidiary CERo Therapeutics Inc. to SRX Global in a stock purchase deal with $8M debt forgiveness (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Exhibits)

SEC EDGAR ·

Tickers: $PBAXU

Read the full article at SEC EDGAR

More Regulatory news